Paper Details

  1. Home
  2. Paper Details

Assessment of Toxic Effects and Survival in Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma: The ORATOR2 Phase 2 Randomized Clinical Trial.

Author: BanerjeeRobyn, BayleyAndrew, BertheletEric, ChandaranaShamir, ChenJeff, ChungJeffson, DowthwaiteSamuel, DzienisMarcin, EnepekidesDanny, EskanderAntoine, FungKevin, HamiltonSarah, HammondJ Alex, HartRobert, HierMichael, HigginsKevin, HusainZain, JacksonJames E, Johnson-ObasekiStephanie, KaramIrene, KrishnanSuren, KuruvillaSara, KwanKeith, LeHien, MacNeilS Danielle, MendezAdrian, MitchellSylvia, MlynarekAlex, NicholsAnthony C, O'NeilJohn, OdellMichael, PalmaDavid A, ParkerChristina, PoonIan, PrismanEitan, ReadNancy, RichardsonKeith, SathyaJinka, StewartPaul, SultanemKhalil, TenenholtzTodd, TheurerJulie, TranEric, VenkatesanVaragur, WarnerAndrew, WehrliBret, WinquistEric, WuJonn, YooJohn

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Clinical Trial, Phase IIA Phase II trial is a trial that further evaluates the efficacy and safety of a new drug or treatment, whose safety has been confirmed to some extent in a Phase I trial, in a small number of patients.

Overview

A randomized clinical trial of 61 patients with HPV-related oropharyngeal squamous cell carcinomas (OPSCCs) found that primary transoral surgery was associated with an unacceptable risk of grade 5 toxic effects. The study was halted due to these complications.
Paper Details　
Original Abstract of the Article :
IMPORTANCE: The optimal approach for treatment deescalation in human papillomavirus (HPV)-related oropharyngeal squamous cell carcinomas (OPSCCs) is unknown. OBJECTIVE: To assess a primary radiotherapy (RT) approach vs a primary transoral surgical (TOS) approach in treatment deescalation for HPV-re...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052108/

データ提供：米国国立医学図書館（NLM）

Treating Oropharyngeal Squamous Cell Carcinoma: A Tale of Two Approaches

In the world of oncology, we're constantly seeking the most effective and least burdensome treatments for various cancers. This study, published in the Journal of the American Medical Association (JAMA), delves into a key question in head and neck cancer: which approach is better for treating Human Papillomavirus (HPV)-related oropharyngeal squamous cell carcinoma (OPSCC) - radiotherapy (RT) or transoral surgery (TOS)? This research is like exploring two different paths through a vast desert, each with its own challenges and rewards. To find the optimal route, the researchers conducted a randomized clinical trial comparing these two approaches.

Radiotherapy vs. Surgery: Navigating the Desert of Cancer Treatment

The results of this study, like the shifting sands of a desert, revealed a complex landscape. While both treatment arms achieved good swallowing outcomes at 1 year, the TOS arm showed a significant risk of Grade 5 toxic effects, leading to the trial being halted prematurely. These findings highlight the importance of balancing the benefits and risks of different treatments, much like a traveler navigating a treacherous desert landscape.

The Verdict: Balancing Risks and Benefits

This research underscores the importance of careful consideration when choosing treatments for OPSCC. While RT may offer a lower risk of severe complications, the long-term outcomes of TOS remain uncertain and require further investigation. As a wise traveler in the desert learns to adapt to changing conditions, we must continue to refine our understanding of the best treatment strategies for this complex disease.

Dr. Camel's Conclusion

This study offers valuable insights into the treatment landscape for HPV-related OPSCC, highlighting the need for ongoing research to refine our understanding of the long-term benefits and risks of both radiotherapy and transoral surgery. While both approaches offer potential benefits, the risks associated with surgery necessitate further investigation to ensure the best outcomes for patients.
Date :
  1. Date Completed 2022-06-20
  2. Date Revised 2023-04-29
Further Info :

Pubmed ID

35482348

DOI: Digital Object Identifier

PMC9052108

Related Literature

Article Analysis
・Effective treatment of hpv
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.